Abinitio Bio builds foundation models for biomanufacturing, validated against wet lab data. Our first model, Echo, predicts manufacturing outcomes more accurately than standard models, and any pharma or CDMO can adapt it to their own workflow instantly. By making process decisions that take 6-18 months today in hours, we help teams avoid the cost of delay on a single program.
The company was founded by Daniel Mukasa; Nisha Gopal. It is part of YC Spring 2026. It is based in Boston, MA, USA.